- Home
- IPSC vs APT Comparison
IPSC vs APT Comparison
Compare IPSC & APT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPSC
- APT
- Stock Information
- Founded
- IPSC 2019
- APT 1983
- Country
- IPSC United States
- APT Canada
- Employees
- IPSC N/A
- APT N/A
- Industry
- IPSC Medicinal Chemicals and Botanical Products
- APT
- Sector
- IPSC Health Care
- APT
- Exchange
- IPSC Nasdaq
- APT Nasdaq
- Market Cap
- IPSC 62.1M
- APT 61.6M
- IPO Year
- IPSC 2021
- APT 1995
- Fundamental
- Price
- IPSC $0.73
- APT $5.62
- Analyst Decision
- IPSC Strong Buy
- APT
- Analyst Count
- IPSC 5
- APT 0
- Target Price
- IPSC $11.00
- APT N/A
- AVG Volume (30 Days)
- IPSC 493.4K
- APT 29.7K
- Earning Date
- IPSC 03-13-2025
- APT 03-12-2025
- Dividend Yield
- IPSC N/A
- APT N/A
- EPS Growth
- IPSC N/A
- APT 20.88
- EPS
- IPSC N/A
- APT 0.37
- Revenue
- IPSC $2,684,000.00
- APT $59,288,000.00
- Revenue This Year
- IPSC $230.60
- APT N/A
- Revenue Next Year
- IPSC $31.83
- APT N/A
- P/E Ratio
- IPSC N/A
- APT $15.20
- Revenue Growth
- IPSC 7.88
- APT 1.88
- 52 Week Low
- IPSC $0.68
- APT $4.64
- 52 Week High
- IPSC $5.51
- APT $6.92
- Technical
- Relative Strength Index (RSI)
- IPSC 30.98
- APT 60.29
- Support Level
- IPSC $0.72
- APT $5.28
- Resistance Level
- IPSC $0.82
- APT $5.50
- Average True Range (ATR)
- IPSC 0.06
- APT 0.18
- MACD
- IPSC 0.01
- APT 0.02
- Stochastic Oscillator
- IPSC 27.43
- APT 37.63
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.
About APT Alpha Pro Tech Ltd.
Alpha Pro Tech Ltd is involved in the business of developing, manufacturing, and marketing of disposable protective apparel, building supply, and infection control products principally in the United States. It operates its business through segment which includes Building Supply and Disposable Protective Apparel. It mainly offers a line of construction supply weatherization products, namely house wrap and synthetic roof underlayment as well as other woven material, different styles of disposable products like shoe covers, bouffant caps, gowns, coveralls, lab coats, frocks and other miscellaneous products. It also provides face masks and eye shields. It generates most of its revenues from the sale of products across the United States.